Natixis Advisors
MEDP icon

Natixis Advisors’s Medpace MEDP Stock Holding History

Natixis Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104M Buy
195,579
+20,864
+12% +$9.63M 0.12% 170
2026
Q1 		$83.9M Buy
174,715
+11,355
+7% +$5.81M 0.12% 176
2025
Q4 		$91.8M Buy
163,360
+13,412
+9% +$7.61M 0.13% 165
2025
Q3 		$77.1M Buy
149,948
+11,838
+9% +$5.17M 0.11% 186
2025
Q2 		$43.3M Buy
138,110
+124,255
+897% +$37.3M 0.07% 274
2025
Q1 		$4.22M Sell
13,855
-432
-3% -$145K 0.01% 853
2024
Q4 		$4.75M Buy
14,287
+3,042
+27% +$1.03M 0.01% 837
2024
Q3 		$3.75M Buy
+11,245
New +$4.27M 0.01% 905
2020
Q4 		– Sell
-17,034
Closed -$1.9M – 1232
2020
Q3 		$1.9M Sell
17,034
-2,193
-11% -$254K 0.01% 804
2020
Q2 		$1.79M Buy
19,227
+130
+0.7% +$11.1K 0.01% 834
2020
Q1 		$1.4M Buy
+19,097
New +$1.66M 0.01% 826

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Natixis Advisors's MEDP Position: Q2 2026 in Review

Natixis Advisors increased its Medpace (MEDP) stake by 12% in Q2 2026, buying an estimated $9.63M and bringing the position to 195,579 shares worth $104M. The position accounts for 0.12% of the portfolio, ranked #170.

Natixis Advisors first reported a position in MEDP in Q1 2020 and has held it in 11 quarters since. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Natixis Advisors held 195,579 shares of Medpace worth $104M as of Q2 2026.
  • Natixis Advisors bought 20,864 Medpace shares in Q2 2026, an estimated $9.63M.
  • Medpace made up 0.12% of Natixis Advisors's portfolio in Q2 2026, its #170 holding.
  • Natixis Advisors first reported a position in Medpace in Q1 2020 and has held it in 11 quarters since.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.